课题基金 / 基金详情

Regulatory T cells and Inflammatory Injury of the Developing Murine Lungs

Regulatory T cells and Inflammatory Injury of the Developing Murine Lungs
调节性 T 细胞和小鼠肺发育中的炎症损伤
批准号:
10368051
负责人:
Binoy Shivanna
金额:
$8.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-08 至 2023-05-31

项目摘要

项目成果

Binoy Shivanna的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract/Summary Bronchopulmonary dysplasia (BPD) is the most common chronic infantile lung disease that lacks curative therapies. Further, BPD increases the economic burden and long-term morbidities in preterm infants. Sepsis-mediated persistent lung inflammation is central to the pathogenesis of BPD, which is characterized by interrupted lung development, i.e., alveolar simplification. However, the molecular mechanisms that modulate neonatal lung inflammation are poorly understood. Regulatory T cells (Tregs) are crucial to maintain immune homeostasis and prevent tissue damage. Further, they promote resolution of lung inflammation and injury in adult animals; however, the role of Tregs in BPD pathogenesis remains unclear. Additionally, the mechanisms of Treg recruitment in neonatal lungs are poorly studied. So, we propose to address these knowledge gaps using a neonatal mouse model of lipopolysaccharide (LPS)-induced chronic inflammatory lung injury. Our preliminary studies in neonatal mice indicate that: (1) LPS decreases Tregs and their C-C motif chemokine receptor 5 (CCR5) expression in lungs; and (2) Treg depletion induces inflammation and potentiates LPS- mediated lung injury. Based on our novel data, we will test the central hypothesis that Tregs are necessary and sufficient to protect against LPS-induced inflammatory lung injury in neonatal mice. We will use a unique combination of molecular, cellular, and functional approaches to test this hypothesis. In Aim 1, we will use transgenic mice to determine if Tregs are necessary and sufficient to protect neonatal mice against LPS- induced lung and pulmonary vascular injury and dysfunction. In Aim 2, we will use transgenic mice to examine the mechanisms of lung Treg recruitment. We expect that successful completion of these studies would provide a mechanistic rationale for targeting Tregs to develop meaningful therapies for BPD infants. Our studies also could positively impact other inflammation-related neonatal research areas, including necrotizing enterocolitis, retinopathy of prematurity, and periventricular leukomalacia.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/jcm11030557
发表时间: 2022-01-22
期刊: Journal of clinical medicine
影响因子: 3.9
作者: [Kalikkot Thekkeveedu R, El-Saie A, Prakash V, Katakam L, Shivanna B]
通讯作者: Shivanna B
DOI: 10.3390/antiox13010078
发表时间: 2024-01-08
期刊: ANTIOXIDANTS
影响因子: 7
作者: [Thapa, Shyam, Shankar, Nithyapriya, Shrestha, Amrit Kumar, Civunigunta, Monish, Gaikwad, Amos S., Shivanna, Binoy, Liu, Jiankang]
通讯作者: Liu, Jiankang
Mechanistic Roles of Adrenomedullin and its Signaling Receptors in Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
  • 批准号:
    10458644
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2018
  • 负责人:
    Binoy Shivanna
  • 依托单位:
Mechanistic Roles of Adrenomedullin and its Signaling Receptors in Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
  • 批准号:
    9981816
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2018
  • 负责人:
    Binoy Shivanna
  • 依托单位:
Mechanistic Roles of Adrenomedullin and its Signaling Receptors in Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
  • 批准号:
    10226114
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2018
  • 负责人:
    Binoy Shivanna
  • 依托单位:
Mechanistic Roles of Adrenomedullin and its Signaling Receptors in Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
  • 批准号:
    9767851
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2018
  • 负责人:
    Binoy Shivanna
  • 依托单位:
海外基金